Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2025Journal of Blood MedicineOpen Access

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRicardo ParrondoJacksonville CollegeEAErnesto AyalaUniversity of North Carolina at Chapel HillMIMadiha IqbalMayo Clinic in Florida

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Parrondo et al. (2025) studied this question.

synapsesocial.com/papers/6aa4a3d6997531f8901426e7https://doi.org/10.2147/jbm.s489627
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma2017 · 1,269 citations
  2. 2Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population2003 · 941 citations
  3. 3A population-based study on incidence trends of myeloma in the United States over 2000–20202023 · 31 citations
  4. 4Thalidomide Attenuates Skin Lesions and Inflammation in Rosacea-Like Mice Induced by Long-Term Exposure of LL-372022 · 19 citations
  5. 5Human autoimmune diseases: a comprehensive update2015 · 1,189 citations